Notice of Funding Opportunity PS24-0047: High-Impact HIV Prevention and Surveillance Programs for Health Departments

Executive Summary

CDC announces the availability of fiscal year 2024 funds for a cooperative agreement for health departments to implement high-impact HIV prevention and surveillance programs. The purpose of this notice of funding opportunity (NOFO) is to implement a comprehensive HIV prevention and surveillance program to prevent new HIV infections and improve the health of peoples with HIV. The NOFO aligns with CDC’s Division of HIV Prevention (DHP) strategic focus areas to bolster community engagement, health equity, syndemic and whole-person approaches to HIV prevention.

Please access the NOFO by searching “CDC-RFA-PS-24-0047” to complete your application package using www.grants.gov.

Eligibility Information

The funding opportunity is for eligible health departments for core prevention and surveillance funding. Approximately 32 additional awards for eligible health departments representing the 57 jurisdictions (48 counties, District of Columbia (DC), San Juan, PR, and 7 states) included in the Ending the HIV Epidemic in the US initiative.

Funding Tables and Resource Distribution

• Funding Tables for Core HIV Prevention and Surveillance and Ending the HIV Epidemic (EHE) [PDF – 309 KB]
• Counties per state representing 30% or greater HIV diagnosis in 2021 for funding distribution [PDF – 193 KB]

Recipient Information

• Recipient Funding Amounts Year 1 (2024) [PDF – 137 KB]

Attachments and Information Resources

Below is the list of Program Guidance and/or related links referenced in the NOFO.

High Impact Prevention (HIP)

• High Impact HIV Prevention CDC’s Approach to Reducing HIV Infections in the United States

HIV Testing

• Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings, 2006
• Implementing HIV Testing in Nonclinical Settings – A Guide for HIV Testing Providers, 2016

Partner Services

• Recommendations for Partner Services Programs for HIV Infection, Syphilis, Gonorrhea, and Chlamydial Infection, 2008

PrEP Guidance

• CDC PrEP Ancillary Support Services Program Guidance for Health Departments (Revised December 2021)
• CDC PrEP Program Guidance for HIV Prevention Health Department Grantees (Revised August 2012) (link retired)
• Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2021 Clinical Practice Guideline
• Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV—United States, 2016

HIV Planning Group (HPG) – Plans and Processes

• HIV Planning Guidance, 2012
• Integrated HIV Prevention and Care Plan Guidance, including the Statewide Coordinated Statement of Need, CY 2017- 2021
• EHE Planning Guidance, 2019

Epidemiologic Profile Guidance

• Integrated Guidance for Developing Epidemiologic Profiles – HIV Prevention and Ryan White HIV/AIDS Programs Planning, 2014

Social Determinants of Health

• The U.S. Playbook to Address Social Determinants of Health – SDOH-Playbook-3.pdf (whitehouse.gov)
• HHS Call to Action: Addressing Health-Related Social Needs in Communities Across the Nation (hhs.gov) – Call to Action: Addressing Health-Related Social Needs in Communities Across the Nation (hhs.gov)

Syringe Services Program (SSP)

• HHS SSP Implementation Guidance 2016 (cdc.gov)
• CDC Program Guidance for Implementing Certain Components of Syringe Services Programs, 2016
• SSP Technical Package (Syringe Services Programs (SSPs) | CDC)

Cluster Detection and Response

• HIV Cluster Detection and Response Guidance for Health Departments

Community Engagement

• Principles of Community Engagement (Second Edition) (cdc.gov)

Perinatal HIV Prevention Program Guidance

• Perinatal Program Guidance [PDF – 259 KB]

Prevention with Positives (PwP) Guidelines

• Recommendations for HIV prevention with adults and adolescents with HIV in the United States, 2014

Data-to-Care (D2C)

• Data to Care | Treat | Effective Interventions | HIV/AIDS | CDC
• Data-to-Care Program Guidance [PDF – 317 KB]
• Data-to-Care Reporting Guidance [PDF – 2 MB]

Laboratory Testing Guidance

• Laboratory testing for the diagnosis of HIV infection: updated recommendations, 2014

Data Security and Confidentiality Guidance

• Data Security and Confidentiality Guidelines for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Programs, 2011
• Certification of compliance with the CDC Data Security and Confidentiality Guidelines and Designation of Overall Responsible Party (ORP) Assurance of Confidentiality Statement [PDF – 211 KB]

Content Review Guidelines

• Program Guidance on the Review of HIV-related Educational and Information Materials for CDC Assistance Programs, updated June 2016
• Assurance of Compliance Form for the Program Guidance on the Review of HIV-related Educational and Information Materials for CDC Assistance Programs, updated June 2016

HIV Surveillance

• HIV Surveillance Overview
• HIV Surveillance Systems

Letter of Intent

CDC strongly urges you to complete a LOI prior to the submission of your application. The purpose of this letter is to inform CDC of your interest in applying for funding under PS24-0047. Although a LOI is not required and non-binding, it is highly recommended as it allows CDC program staff to estimate the number of and plan for the review of submitted applications.

Completed LOI must be electronically submitted to NOFOINFO@cdc.gov

An email acknowledging CDC’s receipt of a LOI submission will be sent to the potential applicant.

Frequently Asked Questions

• PS-24-0047 Frequently Asked Questions [PDF – 159 KB]

After you Apply

Application Submission

The application must include complete, stand-alone sections (e.g. project abstract, narrative, budget and budget justification) for each requested funding program (core and demonstration project) so that each request for a funding program can be identified and provided to the respective review panel. Each detailed budget and narrative justification should support the activities for the first year of funding in response to this NOFO and a summary narrative for the entire project period.

Application Review Information

Applications will be reviewed for completeness. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified if the application did not meet submission requirements. All eligible and technically acceptable applications will be funded for the core HIV program. For demonstration projects, all applications deemed eligible and technically acceptable by the review panel will be funded in order of score and rank, availability of funds, geographic diversity, and relevance to DHAP program priorities.

Notice of Award (NoA)

Successful applicants will receive a Notice of Award (NoA) from the CDC Office of Grants Services (OGS). The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and emailed to the principle investigator (PI) and a hard copy mailed to the recipient fiscal officer identified in the application.

Any application awarded in response to this NOFO will be subject to the DUNS, CCR Registration and Transparency Act requirements.

Contacts

For programmatic technical assistance, contact:
Erica K. Dunbar, Senior Advisor for Program
Department of Health and Human Services
Centers for Disease Control and Prevention
1600 Clifton Road, NE
Atlanta, GA 30333
Email: nofoinfo@cdc.gov

For financial, awards management, or budget assistance, contact:
Edna Green, Grants Management Specialist
Department of Health and Human Services
Office of Grants Services
Atlanta, GA 30341
Email: ecg4@cdc.gov

For assistance with submission difficulties related to www.grants.gov, contact the Contact Center by phone at 1-800-518-4726. Hours of Operation: 24 hours a day, 7 days a week, except on federal holidays.

For all other submission questions, contact:
Technical Information Management Section
Department of Health and Human Services
CDC Office of Financial Resources
Office of Grants Services
2920 Brandywine Road, MS E-14
Atlanta, GA 30341
Telephone: 770-488-2700
Email: ogstims@cdc.gov

CDC Telecommunications for persons with hearing loss is available at: TTY 1-888-232-6348.